EGLN3 and central nervous system cancer: Consistent with previous studies [43], Egln3H196A was expressed at levels comparable to wild-type Egln3 in Hu-glioma cells in vitro and did not promote the degradation of Hif-1α or Hif-2α (Figure 7A).